An investigational medication is what is being studied to see if symptoms improve while taking it. It is not yet approved for general use by regulatory authorities. This study uses an investigational medication called Riliprubart. The investigational medicine is injected in a vein or under the skin, either at the …
These clinical studies are investigating the safety and efficacy of an investigational medication for patients with moderate to severe COPD and who are either current smokers or have a history of smoking.
This study investigates the treatment of IgG4-related disease in adults using an investigational medication compared to a placebo. The study will last up to 60 weeks, including a 4 to 6-week screening period, a 52-week treatment period, and 2 weeks of follow-up. Participants will be in the study for the …
This study investigates the effects of an investigational medication compared to a placebo in adults with high-risk asthma. The purpose is to evaluate the safety and effectiveness of this add-on therapy in participants who are not eligible for biologic treatments. Participants will be involved in the study for about 64 …
This study investigates warm autoimmune hemolytic anemia (wAIHA). Participants will be in the study for up to 24 weeks in the primary analysis period, followed by 28 weeks in an open-label period, and potentially up to 52 weeks in a long-term extension, depending on response. The purpose is to evaluate …
This study investigates the efficacy and safety of an investigational medication in young boys aged 1 to less than 12 years with severe hemophilia A or B. The purpose of this study is to see how well the investigational medication works and how safe it is for children. Participants will …
This study investigates the effects of an investigational medication on adults with moderate to severe Crohn's Disease. The purpose is to evaluate the safety and effectiveness of different doses compared to a placebo. Participants will be in the study for up to 59 weeks, including a 4-week screening period, 52 …
This study investigates the efficacy and safety of an investigational medication in adults with moderate-to-severe ulcerative colitis. Participants will be in the study for up to 59 weeks, including a 28-day screening period, a 52-week main treatment period, and a 2-week follow-up. The main treatment period consists of a 12-week …
